.

0 (hodnocen0 x )

(3.5) Půjčeno:21x 

BK

Eleventh edition

Philadelphia : Wolters Kluwer, [2015]

xvi, 1472 stran : ilustrace, portréty ; 27 cm

ISBN 978-1-4511-9434-0 (brožováno)

Terminologický slovník

Obsahuje bibliografie a rejstřík

001452366

1 Neural Sciences 1 // 1.1 Introduction 1 // 1.2 Functional Neuroanatomy 4 // 1.3 Neural Development and Neurogenesis 18 // 1.4 Neurophysiology and // Neurochemistry 35 // 1.5 Psychoneuroendocrinology 63 // 1.6 Immune System and Central Nervous System Interactions 67 // 1.7 Neurogenetics 71 // 1.8 Applied Electrophysiology 84 // 1.9 Chronobiology 88 // 2 Contributions of the // Psychosocial Sciences 93 // 2.1 Jean Piaget and Cognitive Development 93 // 2.2 Attachment Theory 97 // 2.3 Learning Theory 101 // 2.4 Biology of Memory 110 // 2.5 Normality and Mental Health 123 // 3 Contributions of the Sociocultural Sciences 131 // 3.1 Sociobiology and Ethology 131 // 3.2 Transcultural Psychiatry 139 // 3.3 Culture-Bound Syndromes 145 // 4 Theories of Personality and Psychopathology 151 // 4.1 Sigmund Freud: Founder of Classic Psychoanalysis 151 // 4.2 Erik H. Erikson 167 // Examination and Diagnosis of the Psychiatric Patient 192 // 4.3 Other Psychodynamic Schools 174 // 4.4 Positive Psychology 188 // 5 Examination and Diagnosis of the Psychiatric Patient 192 // 5.1 Psychiatric Interview, History, and Mental Status Examination 192 // 5.2 The Psychiatric Report and Medical Record 211 // 5.3 Psychiatric Rating Scales 217 // 5.4 Clinical Neuropsychology and Intellectual Assessment of Adults 236 // 5.5 Personality Assessment: Adults and Children 246 // 5.6 Neuropsychological and Cognitive Assessment of Children 257 // 5.7 Medical Assessment and Laboratory Testing in Psychiatry 266 // 5.8 Neuroimaging 275

// 5.9 Physical Examination of the Psychiatric Patient 283 // 6. Classification in Psychiatry 290 // 7. Schizophrenia Spectrum and Other Psychotic Disorders 300 // 7.1 Schizophrenia 300 // 7.2 Schizoaffective Disorder 323 // 7.3 Schizophreniform Disorder 327 // 7.4 Delusional Disorder and Shared // Psychotic Disorder 330 // 7.5 Brief Psychotic Disorder, Other Psychotic Disorders, and Catatonia 339 // 8 Mood Disorders 347 // 8.1 Major Depression and Bipolar Disorder 347 // 8.2 Dysthymia and Cyclothymia 380 // 9 Anxiety Disorders 387 // 9.1 Overview 387 // 9.2 Panic Disorder 392 // 9.3 Agoraphobia 398 // 9.4 Specific Phobia 400 // 9.5 Social Anxiety Disorder (Social Phobia) 405 // 9.6 Generalized Anxiety Disorder 407 // 9.7 Other Anxiety Disorders 413 // 10 Obsessive-Compulsive and Related Disorders 418 // 10.1 Obsessive-Compulsive Disorder 418 // 10.2 Body Dysmorphic Disorder 427 // 10.3 Hoarding Disorder 429 // 10.4 Hair-Pulling Disorder (Trichotillomania) 431 // 10.5 Excoriation (Skin-Picking) Disorder 434 // 11. Trauma- and Stressor-Related Disorders 437 // 11.1 Posttraumatic Stress Disorder and Acute Stress Disorder 437 // 11.2 Adjustment Disorders 446 // 12. Dissociative Disorders 451 // 13. Psychosomatic Medicine 465 // 13.1 Introduction and Overview 465 // 13.2 Somatic Symptom Disorder 468 // 13.3 Illness Anxiety Disorder 471 // 13.4 Functional Neurological Symptom Disorder (Conversion Disorder) 473 // 13.5 Psychological Factors Affecting Other Medical Conditions 477 // 13.6 Factitious Disorder 489 // 13.7 Pain Disorder 496 // 13.8 Consultation-Liaison Psychiatry 499 // 14 Chronic Fatigue Syndrome and Fibromyalgia 504 // 15 Feeding and Eating Disorders 509 // 15.1 Anorexia Nervosa 509 // 15.2 Bulimia Nervosa 516 // 15.3 Binge Eating Disorder and Other Eating Disorders 519 // 15.4 Obesity and the Metabolic Syndrome 522 //

16 Normal Sleep and Sleep-Wake Disorders 533 // 16.1 Normal Sleep 533 // 16.2 Sleep-Wake Disorders 536 // 17. Human Sexuality and Sexual Dysfunctions 564 // 17.1 Normal Sexuality 564 // 17.2 Sexual Dysfunctions 575 // 17.3 Paraphilic Disorders 593 // 18 Gender Dysphoria 600 // 19 Disruptive, Impulse-Control, and Conduct Disorders 608 // 20 Substance Use and Addictive Disorders 616 // 20.1 Introduction and Overview 616 // 20.2 Alcohol-Related Disorders 624 // 20.3 Caffeine-Related Disorders 639 // 20.4 Cannabis-Related Disorders 644 // 20.5 Hallucinogen-Related Disorders 648 // 20.6 Inhalant-Related Disorders 656 // 20.7 Opioid-Related Disorders 659 // 20.8 Sedative-, Hypnotic-, or Anxiolytic-Related Disorders 666 // 20.9 Stimulant-Related Disorders 671 // 20.10 Tobacco-Related Disorders 680 // 20.11 Anabolic-Androgenic Steroid Abuse 685 // 20.12 Other Substance Use and Addictive Disorders 689 // 20.13 Gambling Disorder 690 // 21 Neurocognitive Disorders 694 // 21.1 Introduction and Overview 694 // 21.2 Delirium 697 // 21.3 Dementia (Major Neurocognitive Disorder) 704 // 21.4 Major or Minor Neurocognitive Disorder Due to Another Medical Condition (Amnestic Disorders) 718 // 21.5 Neurocognitive and Other Disorders Due to a General Medical Condition 723 // 21.6 Mild Cognitive Impairment 737 // 22 Personality Disorders 742 // 23 Emergency Psychiatric Medicine 763 // 23.1 Suicide 763 // 23.2 Psychiatric Emergencies in Adults 774 // 23.3 Psychiatric Emergencies in Children 785 // 24 Complementary and Alternative Medicine in Psychiatry 791 // 25 Other Conditions that May be a Focus of Clinical Attention 812 // 26 Physical and Sexual Abuse of Adults 824 // 27 Psychiatry and Reproductive Medicine 831 // 28 Psychotherapies 845 // 28.1 Psychoanalysis and Psychoanalytic Psychotherapy 845 // 28.2 Brief Psychodynamic Psychotherapy 853 // 28.3 Group Psychotherapy, Combined Individual and Group Psychotherapy, and Psychodrama 857 //

28.4 Family Therapy and Couples Therapy 863 // 28.5 Dialectical Behavior Therapy 868 // 28.6 Biofeedback 869 // 28.7 Cognitive Therapy 873 // 28.8 Behavior Therapy 877 // 28.9 Hypnosis 883 // 28.10 Interpersonal Therapy 887 // 28.11 Narrative Psychotherapy 891 // 28.12 Psychiatric Rehabilitation 894 // 28.13 Combined Psychotherapy and Pharmacology 897 // 28.14 Genetic Counseling 901 // 28.15 Mentalization-Based Therapy and Mindfulness 907 // 29 Psychopharmacological Treatment 910 // 29.1 General Principles of Psychopharmacology 910 // 29.2 Medication-Induced Movement Disorders 923 // 29.3 α-Adrenergic Receptor Agonists, α1-Adrenergic Receptor Antagonists: Clonidine, Guanfacine, Prazosin, and Yohimbine 929 // 29.4 ß-Adrenergic Receptor Antagonists 933 // 29.5 Anticholinergic Agents 936 // 29.6 Anticonvulsants 938 // 29.7 Antihistamines 942 // 29.8 Barbiturates and Similarly Acting Drugs 944 // 29.9 Benzodiazepines and Drugs Acting on GABA Receptors 948 // 29.10 Bupropion 954 // 29.11 Buspirone 956 // 29.12 Calcium Channel Blockers 957 // 29.13 Carbamazepinc and Oxcarbazepine 959 // 29.14 Cholinesterase Inhibitors and Memantine 963 // 29.15 Disulfiram and Acamprosate 966 // 29.16 Dopamine Receptor Agonists and Precursors 969 // 29.17 Dopamine Receptor Antagonists (First-Generation Antipsychotics) 972 // 29.18 Lamotrigine 981 // 29.19 Lithium 983 // 29.20 Melatonin Agonists: Ramelteon and Melatonin 991 // 29.21 Mirtazapine 993 // 29.22 Monoamine Oxidase Inhibitors 994 // 29.23 Nefazodone and Trazodone 997 // 29.24 Opioid Receptor Agonists 1000 // 29.25 Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone 1004 // 29.26 Phosphodiesterase-5 Inhibitors 1008 // 29.27 Selective Serotonin- Norepinephrine Reuptake Inhibitors 1010 // 29.28 Selective Serotonin Reuptake Inhibitors 1013 // 29.29 Serotonin-Dopamine Antagonists and Similarly Acting Drugs (Second-Generation or Atypical Antipsychotics) 1023 // 29.30 Stimulant Drugs and Atomoxetine 1033 //

29.31 Thyroid Hormones 1039 // 29.32 Tricyclics and Tetracyclics 1040 // 29.33 Valproate 1045 // 29.34 Nutritional Supplements and Medical Foods 1049 // 29.35 Weight Loss Drugs 1060 // 30 Brain Stimulation Methods 1065 // 30.1 Electroconvulsive Therapy 1065 // 30.2 Other Brain Stimulation Methods 1072 // 30.3 Neurosurgical Treatments and Deep Brain Stimulation 1077 // 31 Child Psychiatry 1082 // 31.1 Introduction: Infant, Child, and Adolescent Development 1082 // 31.2 Assessment, Examination, and Psychological Testing 1107 // 31.3 Intellectual Disability 1118 // 31.4 Communication Disorders 1137 // 31.4a Language Disorder 1137 // 31.4b Speech Sound Disorder 1144 // 31.4c Child-Onset Fluency Disorder (Stuttering) 1147 // 31.4d Social (Pragmatic) Communication Disorder 1149 // 31.4e Unspecified Communication Disorder 1151 // 31.5 Autism Spectrum Disorder 1152 // 31.6 Attention Deficit/Hyperactivity Disorder 1169 // 31.7 Specific Learning Disorder 1181 // 31.8 Motor Disorders 1190 // 31.8a Developmental Coordination Disorder 1190 // 31.8b Stereotypic Movement Disorder 1194 // 31.8c Tourette’s Disorder 1197 // 31.8d Persistent (Chronic) Motor or Vocal Tic Disorder 1205 // 31.9 Feeding and Eating Disorders of Infancy or Early Childhood 1205 // 31.9a Pica 1206 // 31.9b Rumination Disorder 1207 // 31.9c Avoidant/Restrictive Food Intake Disorder 1209 // 31.10 Elimination Disorders 1211 // 31.10a Encopresis 1212 // 31.10b Enuresis 1214 // 31.11 Trauma- and Stressor-Related Disorders in Children 1216 // 31.11a Reactive Attachment Disorder and Disinhibited Social Engagement Disorder 1217 // 31.11b Posttraumatic Stress Disorder of Infancy, Childhood, and Adolescence 1221 // 31.12 Mood Disorders and Suicide in Children and Adolescents 1226 // 31.12a Depressive Disorders and Suicide in Children and Adolescents 1226 // 31.12b Early-Onset Bipolar Disorder 1236 // 31.12c Disruptive Mood Dysregulation Disorder 1242 // 31.12d Oppositional Defiant Disorder 1244 //

31.12e Conduct Disorder 1247 // 31.13 Anxiety Disorders of Infancy, Childhood, and Adolescence 1253 // 31.13a Separation Anxiety Disorder, Generalized Anxiety Disorder, and Social Anxiety Disorder (Social Phobia) 1253 // 31.13b Selective Mutism 1261 // 31.14 Obsessive-Compulsive Disorder in Childhood and Adolescence 1263 // 31.15 Early-Onset Schizophrenia 1268 // 31.16 Adolescent Substance Abuse 1273 // 31.17 Child Psychiatry: Other Conditions 1279 // 31.17a Attenuated Psychosis Syndrome 1279 // 31.17b Academic Problem 1280 // 31.17c Identity Problem 1282 // 31.18 Psychiatric Treatment of Children and Adolescents 1283 // 31.18a Individual Psychotherapy 1283 // 31.18b Group Psychotherapy 1288 // 31.18c Residential, Day, and Hospital Treatment 1291 // 31.18d Pharmacotherapy 1295 // 31.18e Psychiatric Treatment of Adolescents 1301 // 31.19 Child Psychiatry: Special Areas of Interest 1305 // 31.19a Forensic Issues in Child Psychiatry 1305 // 31.19b Adoption and Foster Care 1310 // 31.19c Child Maltreatment and Neglect 1314 // 31.19d Impact of Terrorism on Children 1320 // 32 Adulthood 1325 // 33 Geriatric Psychiatry 1334 // 34 End-of-Life Issues 1352 // 34.1 Death, Dying, and Bereavement 1352 // 34.2 Palliative Care 1359 // 34.3 Euthanasia and Physician-Assisted Suicide 1370 // 35 Public Psychiatry 1374 // 36 Forensic Psychiatry and Ethics in Psychiatry 1381 // 36.1 Forensic Psychiatry 1381 // 36.2 Ethics in Psychiatry 1392 // 37 World Aspects of Psychiatry 1400 // Glossary Signs and Symptoms in Psychiatry 1407 // Index 1419